Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
MannKind Announces First Patient Enrolled in INHALE-1ST Pediatric Study Evaluating Afrezza® for Youth with Newly-Diagnosed Type 1 Diabetes (T1D)
-
CHARLOTTE, NC, Feb. 05, 2026 (GLOBE NEWSWIRE) -- His Choice Health today announced the upcoming opening of its newest clinic in Charlotte, targeted late February 2026, bringing its highly regarded,...
-
Dubai, Feb. 05, 2026 (GLOBE NEWSWIRE) -- - Vibe Marketing Tech Fest 2026 is set to take place on April 22-23, 2026, at the Hilton Palm Jumeirah in Dubai. The summit will share behind-the-scenes...
-
MONTRÉAL, 05 févr. 2026 (GLOBE NEWSWIRE) -- Osisko Metals Incorporated (la « Société » ou « Osisko ») (TSX : OM; OTCQX : OMZNF; FRANKFURT : 0B51) annonce les premiers résultats suivant le...
-
Osisko Metals announces initial results from the re-evaluation of the Gaspé Copper Project’s Porphyry Mountain deposit, discovered in 1994 by Noranda Inc.
-
Socrates Health Solutions Announces Advances in Proprietary Non-Invasive Glucose Monitoring Technology; Shareholders Include NFL Players Association and On
-
Byonyks’ FDA-cleared X1 advances home dialysis innovation, with Farrukh Usman leading a mission to transform patient-centric renal care globally.
-
EURneffy 1 mg will be the first and only needle-free adrenaline available to younger children in the European Union ARS Pharma’s partner, ALK-Abelló A/S, who owns the rights to market EURneffy in the...
-
CROSSJECT announces initiation of coverage of its stock by Portzamparc (BNP Paribas Group) DIJON, France - February 2, 2026 (7:15 a.m. CET) – CROSSJECT (ISIN: FR0011716265; Euronext: ALCJ), the...
-
Delray Beach, FL, Jan. 30, 2026 (GLOBE NEWSWIRE) -- The global drug device combination products market is projected to reach USD 379.17 billion by 2030, from USD 243.02 billion in 2025, at a CAGR of...